Monoclonal antibody blockade of Pneumocystis carinii GP-130 inhibits attachment to alveolar macrophages

Mehrdad Behnia, T. Weaver, R. Pasula, W. J. Martin

Research output: Contribution to journalArticle

Abstract

Purpose: Pneumocystis carinii (Pc) is a significant cause of morbidity and mortality in the immunocompromised host. Gp130, a mannose-rich glycoprotein on the surface of Pc, has been implicated in the attachment of Pc to alveolar macrophages (AM). Our study proposes to directly test this hypothesis. Methods: Murine AMs were obtained by bronchoalveolar lavage and incubated in 96-well plates for 24 hours. Pc devoid of IgG were isolated from severe combined immunodeficient (SCID) mice and were subsequently labelled with 51Cr. An in vitro attachment assay at 4 C for 4 hours was done using different concentrations of anti-gp130 IgG monoclonal antibodies (MAb). In addition, the attachment of 51Cr labelled Pc to fibronectin-coated plates was assessed in the presence and absence of anti-gp130 MAb. Results: Anti-gp130 MAb reduced the percent attachment of Pc to alveolar macrophages from 26.8±4.8 (n=17) to 10.3±2.4 (n=15) (p<0.05). Percent attachment of Pc to murine fibronectin-coated plates was reduced from 10.1±1.2 (n=3) to 5.8±0.3 (n=3) in the presence of anti-gp130 MAb (p<0.05) and was not affected in the presence of nonspecific IgG. Conclusions: Our data suggests that the surface glycoprotein gp130 is a key protein on the surface of Pc that mediates attachment of Pc to murine alveolar macrophages. Clinical Implications: Manipulation of Pc attachment to the alveolar macrophages through anti- gp130 MAb could have therapeutic potentials in controlling this infection.

Original languageEnglish (US)
JournalCHEST
Volume114
Issue number4 SUPPL.
StatePublished - Oct 1 1998
Externally publishedYes

Fingerprint

Pneumocystis carinii
Alveolar Macrophages
Monoclonal Antibodies
Membrane Glycoproteins
Fibronectins
Immunoglobulin G
2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine
SCID Mice
Immunocompromised Host
Bronchoalveolar Lavage
Mannose
Membrane Proteins
Morbidity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Monoclonal antibody blockade of Pneumocystis carinii GP-130 inhibits attachment to alveolar macrophages. / Behnia, Mehrdad; Weaver, T.; Pasula, R.; Martin, W. J.

In: CHEST, Vol. 114, No. 4 SUPPL., 01.10.1998.

Research output: Contribution to journalArticle

Behnia, Mehrdad ; Weaver, T. ; Pasula, R. ; Martin, W. J. / Monoclonal antibody blockade of Pneumocystis carinii GP-130 inhibits attachment to alveolar macrophages. In: CHEST. 1998 ; Vol. 114, No. 4 SUPPL.
@article{9f836fb3f26e4fccbedb78fffb0e2f24,
title = "Monoclonal antibody blockade of Pneumocystis carinii GP-130 inhibits attachment to alveolar macrophages",
abstract = "Purpose: Pneumocystis carinii (Pc) is a significant cause of morbidity and mortality in the immunocompromised host. Gp130, a mannose-rich glycoprotein on the surface of Pc, has been implicated in the attachment of Pc to alveolar macrophages (AM). Our study proposes to directly test this hypothesis. Methods: Murine AMs were obtained by bronchoalveolar lavage and incubated in 96-well plates for 24 hours. Pc devoid of IgG were isolated from severe combined immunodeficient (SCID) mice and were subsequently labelled with 51Cr. An in vitro attachment assay at 4 C for 4 hours was done using different concentrations of anti-gp130 IgG monoclonal antibodies (MAb). In addition, the attachment of 51Cr labelled Pc to fibronectin-coated plates was assessed in the presence and absence of anti-gp130 MAb. Results: Anti-gp130 MAb reduced the percent attachment of Pc to alveolar macrophages from 26.8±4.8 (n=17) to 10.3±2.4 (n=15) (p<0.05). Percent attachment of Pc to murine fibronectin-coated plates was reduced from 10.1±1.2 (n=3) to 5.8±0.3 (n=3) in the presence of anti-gp130 MAb (p<0.05) and was not affected in the presence of nonspecific IgG. Conclusions: Our data suggests that the surface glycoprotein gp130 is a key protein on the surface of Pc that mediates attachment of Pc to murine alveolar macrophages. Clinical Implications: Manipulation of Pc attachment to the alveolar macrophages through anti- gp130 MAb could have therapeutic potentials in controlling this infection.",
author = "Mehrdad Behnia and T. Weaver and R. Pasula and Martin, {W. J.}",
year = "1998",
month = "10",
day = "1",
language = "English (US)",
volume = "114",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Monoclonal antibody blockade of Pneumocystis carinii GP-130 inhibits attachment to alveolar macrophages

AU - Behnia, Mehrdad

AU - Weaver, T.

AU - Pasula, R.

AU - Martin, W. J.

PY - 1998/10/1

Y1 - 1998/10/1

N2 - Purpose: Pneumocystis carinii (Pc) is a significant cause of morbidity and mortality in the immunocompromised host. Gp130, a mannose-rich glycoprotein on the surface of Pc, has been implicated in the attachment of Pc to alveolar macrophages (AM). Our study proposes to directly test this hypothesis. Methods: Murine AMs were obtained by bronchoalveolar lavage and incubated in 96-well plates for 24 hours. Pc devoid of IgG were isolated from severe combined immunodeficient (SCID) mice and were subsequently labelled with 51Cr. An in vitro attachment assay at 4 C for 4 hours was done using different concentrations of anti-gp130 IgG monoclonal antibodies (MAb). In addition, the attachment of 51Cr labelled Pc to fibronectin-coated plates was assessed in the presence and absence of anti-gp130 MAb. Results: Anti-gp130 MAb reduced the percent attachment of Pc to alveolar macrophages from 26.8±4.8 (n=17) to 10.3±2.4 (n=15) (p<0.05). Percent attachment of Pc to murine fibronectin-coated plates was reduced from 10.1±1.2 (n=3) to 5.8±0.3 (n=3) in the presence of anti-gp130 MAb (p<0.05) and was not affected in the presence of nonspecific IgG. Conclusions: Our data suggests that the surface glycoprotein gp130 is a key protein on the surface of Pc that mediates attachment of Pc to murine alveolar macrophages. Clinical Implications: Manipulation of Pc attachment to the alveolar macrophages through anti- gp130 MAb could have therapeutic potentials in controlling this infection.

AB - Purpose: Pneumocystis carinii (Pc) is a significant cause of morbidity and mortality in the immunocompromised host. Gp130, a mannose-rich glycoprotein on the surface of Pc, has been implicated in the attachment of Pc to alveolar macrophages (AM). Our study proposes to directly test this hypothesis. Methods: Murine AMs were obtained by bronchoalveolar lavage and incubated in 96-well plates for 24 hours. Pc devoid of IgG were isolated from severe combined immunodeficient (SCID) mice and were subsequently labelled with 51Cr. An in vitro attachment assay at 4 C for 4 hours was done using different concentrations of anti-gp130 IgG monoclonal antibodies (MAb). In addition, the attachment of 51Cr labelled Pc to fibronectin-coated plates was assessed in the presence and absence of anti-gp130 MAb. Results: Anti-gp130 MAb reduced the percent attachment of Pc to alveolar macrophages from 26.8±4.8 (n=17) to 10.3±2.4 (n=15) (p<0.05). Percent attachment of Pc to murine fibronectin-coated plates was reduced from 10.1±1.2 (n=3) to 5.8±0.3 (n=3) in the presence of anti-gp130 MAb (p<0.05) and was not affected in the presence of nonspecific IgG. Conclusions: Our data suggests that the surface glycoprotein gp130 is a key protein on the surface of Pc that mediates attachment of Pc to murine alveolar macrophages. Clinical Implications: Manipulation of Pc attachment to the alveolar macrophages through anti- gp130 MAb could have therapeutic potentials in controlling this infection.

UR - http://www.scopus.com/inward/record.url?scp=33750230183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750230183&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750230183

VL - 114

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4 SUPPL.

ER -